|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/32 |
| (11) | Patento numeris | 2513148 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10791036.6 |
| Europos patento paraiškos padavimo data | 2010-12-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/060533 |
| Data | 2010-12-15 |
| (87) | Numeris | WO 2011/084496 |
| Data | 2011-07-14 |
| (30) | Numeris | Data | Šalis |
| 287155 P | 2009-12-16 | US |
| (72) |
HARDING, Fiona A., US
AKAMATSU, Yoshiko, US
DUBRIDGE, Robert B., US
POWERS, David B., US
|
| (73) |
AbbVie Biotherapeutics Inc.,
1500 Seaport Boulevard, Redwood City, CA 94063,
US
|
| (54) | ANTI-HER2 ANTIBODIES AND THEIR USES |
| ANTI-HER2 ANTIBODIES AND THEIR USES |